These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 114976)

  • 1. [Pharmacokinetic perturbations in kidney failure. Anomalies of metabolites and tissue diffusion (author's transl)].
    Fabre J; Balant L; Rudhardt M; Blanchard P
    Nouv Presse Med; 1979 Aug 25-Sep 3; 8(33):2677-82. PubMed ID: 114976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agents.
    Prendergast BD
    Clin Pharm; 1984; 3(5):473-85. PubMed ID: 6435940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aminoglycoside renal cortical kinetics: a clue to mechanisms of nephrotoxicity.
    Whelton A
    Prog Clin Biol Res; 1979; 35():33-41. PubMed ID: 395539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Aminoglycoside nephrotoxicity. I. Clinical aspects, morphology and tissue pharmacokinetics].
    Fabre J
    Nephrologie; 1980; 1(1):37-43. PubMed ID: 7029331
    [No Abstract]   [Full Text] [Related]  

  • 5. Study on pulmonary, prostatic and renal (medulla and cortex) distribution of sagamicin at different time intervals.
    Fraschini F; Braga PC; Scaglione F; Zanollo A; Politi P; Odero R; Trazzi R
    Int J Clin Pharmacol Res; 1987; 7(1):51-8. PubMed ID: 3583487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of the renal cortical uptake and release of aminoglycosides: a rational approach to the understanding and prevention of their nephrotoxicity.
    Giuliano RA; Verpooten GA; De Broe ME
    Dev Toxicol Environ Sci; 1986; 14():105-14. PubMed ID: 3829968
    [No Abstract]   [Full Text] [Related]  

  • 7. Nephrotoxicity of aminoglycosides. Effects on pharmacokinetics and prevention.
    Brogard JM; Comte F; Spach MO
    Contrib Nephrol; 1984; 42():182-95. PubMed ID: 6398194
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prediction of aminoglycoside nephrotoxicity (author's transl)].
    Whelton A
    Nouv Presse Med; 1978 Nov; 7(42):3838-43. PubMed ID: 714689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aminoglycoside nephrotoxicity--a tale of two transports.
    Whelton A; Solez K
    J Lab Clin Med; 1982 Feb; 99(2):148-55. PubMed ID: 7038007
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prevision of aminoglycoside nephrotoxicity (author's transl)].
    Lucht F; Peyramond D; Robert D; Vincent P
    Pathol Biol (Paris); 1982 Apr; 30(4):227-31. PubMed ID: 7045782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clearance concept applied to pharmacokinetics: 2. Experience with tolamolol (beta-blocking agent) in renal insufficiency (author's transl)].
    Balant L; Gorgia A; Marmy A; Tschopp JM
    Nephrologie; 1980; 1(4):177-82. PubMed ID: 6895408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Accumulation and persistence of aminoglycosides in the renal parenchyma].
    Rudhardt M; Blanchard P; Fabre J
    Nouv Presse Med; 1978 Nov; 7(42):3819-23. PubMed ID: 714684
    [No Abstract]   [Full Text] [Related]  

  • 13. [Possibilities of the preclinical assessment of changes in pharmacokinetics as a result of renal failure].
    Schück O; Morávek J; Hatala M
    Cas Lek Cesk; 1983 Jul; 122(29):897-900. PubMed ID: 6616551
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prediction of aminoglycoside nephrotoxicity].
    Lucht F; Peyramond D; Robert D; Vincent P
    Sem Hop; 1982 Sep; 58(35):2021-5. PubMed ID: 6293091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal parenchymal accumulation of aminoglycoside antibiotics in rats.
    Luft FC; Kleit SA
    J Infect Dis; 1974 Dec; 130(6):656-9. PubMed ID: 4427081
    [No Abstract]   [Full Text] [Related]  

  • 16. The intrarenal distribution of aztreonam in healthy and diseased kidneys: clinical therapeutic implications.
    Watson AJ; Stout RL; Whelton A
    J Infect Dis; 1984 Nov; 150(5):631-5. PubMed ID: 6541673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Netilmicin and tobramycin: comparative evaluation of pharmacokinetics, nephrotoxicity, and therapeutic efficacy in animal studies (author's transl)].
    Marre R; Abraham M; Freiesleben H; Sack K
    Arzneimittelforschung; 1979; 29(6):940-5. PubMed ID: 582788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the protective effect of dietary fish oil on gentamicin-induced nephrotoxicity and oxidative damage in rat kidney.
    Priyamvada S; Priyadarshini M; Arivarasu NA; Farooq N; Khan S; Khan SA; Khan MW; Yusufi AN
    Prostaglandins Leukot Essent Fatty Acids; 2008 Jun; 78(6):369-81. PubMed ID: 18556188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the pharmacokinetics of glipizide and glibenclamide in man.
    Balant L; Fabre J; Zahnd GR
    Eur J Clin Pharmacol; 1975; 8(1):63-9. PubMed ID: 823030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Simulation of the pharmacokinetics of aminoglycosides in the kidneys: single and continuous intake of sisomicin and gentamicin by rats].
    Firsov AA; Umnova LV; Fomina IP
    Antibiotiki; 1983 Nov; 28(11):826-34. PubMed ID: 6651271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.